Received: 19 February 2020
Accepted: 16 June 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: Ethical approval was obtained from the National Cancer Institute Institutional Review Board, and written informed consent was obtained from all study participants. Ethical committee approval no.: I-21101h (Ethical committee of Clinical and Chemical Pathology Department, Cairo University Faculty of Medicine).
: Not applicable
: The authors declare that they have no competing interests.